posted on 2021-09-20, 17:46authored bySumeet A. Khetarpal, Cecilia Vitali, Michael G. Levin, Derek Klarin, Joseph Park, Akhil Pampana, John S. Millar, Takashi Kuwano, Dhavamani Sugasini, Papasani V. Subbaiah, Jeffrey T. Billheimer, Pradeep Natarajan, Daniel J. Rader
A. Plasma triglycerides in mice at the indicated timepoints following intraperitoneal injection of poloxamer P407, a competitive inhibitor of LPL activity. Plasma TGs were measured by colorimetric biochemical assays. B. VLDL-TG secretion rates calculated from the slope of the curves from (A) using the 1, 2, and 4 hour timepoints. **P<0.01, repeated factor 2-way ANOVA comparing WT and Lipg-/- groups (A). *P<0.05, student’s unpaired T-test comparing WT and Lipg-/- groups (B). Data is expressed as mean ± S.E.M.